Research with human participants

Overview of medical research in the Netherlands

Biobank Hematological Stem Cell Transplantation

Published:
Last updated:

-

Download: PDF | XML
Ethical review
Approved WMO
Status
Recruiting
Health condition type
Haematological disorders NEC
Study type
Observational non invasive

ID

NL-OMON36036

Source

ToetsingOnline

Brief title

Biobank HSCT

Condition

  • Haematological disorders NEC
  • Immune disorders NEC
  • Viral infectious disorders

Synonym

immune recovery, immunereconstitution

Research involving

Human

Sponsors and support

Primary sponsor :
Universitair Medisch Centrum Utrecht
Source(s) of monetary or material Support :
Ministerie van OC&W

Intervention

Keyword :
biobank, DLI, Immune reconstitution, SCT

Outcome measures

Primary outcome

-

Secondary outcome

-

Background summary

-

Study objective

-

Study design

-

Study burden and risks

-

Public
Universitair Medisch Centrum Utrecht

Lundlaan 6
Postbus 85090/ 3508 AB Utrecht
NL
Scientific
Universitair Medisch Centrum Utrecht

Lundlaan 6
Postbus 85090/ 3508 AB Utrecht
NL

Listed location countries

Netherlands

Age

Adolescents (12-15 years)
Adolescents (16-17 years)
Adults (18-64 years)
Children (2-11 years)
Elderly (65 years and older)

Inclusion criteria

Patient, undergoing Hematological stem cell transplantation, or donor lymfocyte infusion in het UMCU

Exclusion criteria

no informed consent

Design

Study type :
Observational non invasive
Masking :
Open (masking not used)
Control :
Uncontrolled
Primary purpose :
Treatment

Recruitment

NL
Recruitment status
:
Recruiting
Start date (anticipated) :
Enrollment :
0
Type :
Actual

Approved WMO
Date :
Application type :
First submission
Review commission :
METC NedMec

Followed up by the following (possibly more current) registration

No registrations found.

Other (possibly less up-to-date) registrations in this register

No registrations found.

In other registers

Register ID
CCMO NL35448.041.11